This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2017 Feb 9;148(3):132-138.

doi: 10.1016/j.medcli.2016.09.047. Epub 2016 Nov 29.

Diagnosis and treatment of Fabry disease

[Article in English, Spanish]

Alberto Ortiz¹, Maria Dolores Sanchez-Niño²

Affiliations

Affiliations

¹ Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz, School of Medicine, Universidad Autónoma de Madrid, Madrid, España; Red de Investigación Renal (REDINREN), Madrid, España. Electronic address: aortiz@fjd.es.
² Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz, School of Medicine, Universidad Autónoma de Madrid, Madrid, España; Red de Investigación Renal (REDINREN), Madrid, España.

PMID: 27912900
DOI: 10.1016/j.medcli.2016.09.047

Free article

Review

Diagnosis and treatment of Fabry disease

[Article in English, Spanish]

Alberto Ortiz et al. Med Clin (Barc). 2017.

Free article

. 2017 Feb 9;148(3):132-138.

doi: 10.1016/j.medcli.2016.09.047. Epub 2016 Nov 29.

Authors

Alberto Ortiz¹, Maria Dolores Sanchez-Niño²

Affiliations

¹ Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz, School of Medicine, Universidad Autónoma de Madrid, Madrid, España; Red de Investigación Renal (REDINREN), Madrid, España. Electronic address: aortiz@fjd.es.
² Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz, School of Medicine, Universidad Autónoma de Madrid, Madrid, España; Red de Investigación Renal (REDINREN), Madrid, España.

PMID: 27912900
DOI: 10.1016/j.medcli.2016.09.047

No abstract available

PubMed Disclaimer

Comment in

Differences between agalsidase α and agalsidase β in the treatment of Fabry disease.
Pérez-López J, Domínguez Gil-Hurlé A, López Rodríguez M. Pérez-López J, et al. Med Clin (Barc). 2017 Sep 20;149(6):270. doi: 10.1016/j.medcli.2017.03.054. Epub 2017 Jun 8. Med Clin (Barc). 2017. PMID: 28602212 English, Spanish. No abstract available.
Reply.
Ortiz A, Sanchez-Niño MD. Ortiz A, et al. Med Clin (Barc). 2017 Sep 20;149(6):271-272. doi: 10.1016/j.medcli.2017.05.016. Epub 2017 Jun 23. Med Clin (Barc). 2017. PMID: 28651882 English, Spanish. No abstract available.

Similar articles

Screening for Fabry disease using genetic testing.
Weidemann F, Niemann M. Weidemann F, et al. Eur J Heart Fail. 2010 Jun;12(6):530-1. doi: 10.1093/eurjhf/hfq080. Eur J Heart Fail. 2010. PMID: 20498267 No abstract available.
[Fabry disease--guidelines for diagnosis and management of adult patients].
Merkler M, Pećin I, Simić I, Muacević-Katanec D, Sućur N, Reiner Z. Merkler M, et al. Lijec Vjesn. 2014 May-Jun;136(5-6):133-5. Lijec Vjesn. 2014. PMID: 25154181 Croatian.
X-linked inheritance and its implication in the diagnosis and management of female patients in Fabry disease.
Germain DP, Benistan K, Angelova L. Germain DP, et al. Rev Med Interne. 2010 Dec;31 Suppl 2:S209-13. doi: 10.1016/S0248-8663(10)70013-8. Rev Med Interne. 2010. PMID: 21211665 No abstract available.
[Fabry's disease, recommendation for diagnostics, follow up and treatment in Finland].
Penttinen M, Kantola I, Nuutila P, Hietaharju A, Honkanen E, Kaitila I, Niskanen L, Savolainen M, Viikari J. Penttinen M, et al. Duodecim. 2004;120(20):2407-14. Duodecim. 2004. PMID: 15641509 Review. Finnish. No abstract available.
Fabry disease--a metabolic disorder with a challenge for endocrinologists?
Feldt-Rasmussen U, Rasmussen AK, Mersebach H, Rosenberg KM, Hasholt L, Sorensen SA. Feldt-Rasmussen U, et al. Horm Res. 2002;58(6):259-65. doi: 10.1159/000066443. Horm Res. 2002. PMID: 12446988 Review.

See all similar articles

Cited by

Mulberry bodies in the urine sediment of a patient with chronic kidney disease.
Martínez-Figueroa C, Cortés-Sarabia K, Catalán-Nájera HG, Martínez-Alarcón M. Martínez-Figueroa C, et al. Adv Lab Med. 2020 May 5;1(3):20200028. doi: 10.1515/almed-2020-0028. eCollection 2020 Oct. Adv Lab Med. 2020. PMID: 37361502 Free PMC article.
Fabry Disease p.M290I Mutation is Related to Organ Involvement: A Case Report.
Silva F, Pestana N, Durães J, Guimarães Rosa N, Silva G. Silva F, et al. Cureus. 2021 Mar 25;13(3):e14100. doi: 10.7759/cureus.14100. Cureus. 2021. PMID: 33907643 Free PMC article.
Clinical proteomics in kidney disease as an exponential technology: heading towards the disruptive phase.
Sanchez-Niño MD, Sanz AB, Ramos AM, Fernandez-Fernandez B, Ortiz A. Sanchez-Niño MD, et al. Clin Kidney J. 2017 Apr;10(2):188-191. doi: 10.1093/ckj/sfx023. Epub 2017 Mar 31. Clin Kidney J. 2017. PMID: 28396735 Free PMC article.
Platelet and myeloid cell phenotypes in a rat model of Fabry disease.
Kanack AJ, Aoki K, Tiemeyer M, Dahms NM. Kanack AJ, et al. FASEB J. 2021 Aug;35(8):e21818. doi: 10.1096/fj.202001727RR. FASEB J. 2021. PMID: 34320241 Free PMC article.
Case report: enzyme replacement therapy for Fabry disease presenting with proteinuria and ventricular septal thickening.
Chen Z, Yin B, Jiao J, Ye T. Chen Z, et al. BMC Nephrol. 2024 Feb 21;25(1):61. doi: 10.1186/s12882-024-03499-w. BMC Nephrol. 2024. PMID: 38383316 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- Genetic Alliance